STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

100 hedge funds and large institutions have $445M invested in Stemline Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 56 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+4
Holders Change %
+4.17%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
17
Increased
56
Reduced
18
Closed
13
Calls
$292K
Puts
$932K
Net Calls
-$640K
Net Calls Change
+$860K
Name Holding Trade Value Shares
Change
Shares
Change %
KAM
101
Kavi Asset Management
New York
-$5.93M -387,313 Closed
FI
102
Fosun International
China
-$3.21M -212,936 Closed
ARTA
103
A.R.T. Advisors
New York
-$753K -49,172 Closed
TD Asset Management
104
TD Asset Management
Ontario, Canada
-$590K -38,494 Closed
Two Sigma Advisers
105
Two Sigma Advisers
New York
-$342K -22,300 Closed
RJA
106
Raymond James & Associates
Florida
-$247K -16,150 Closed
OFS
107
OneAscent Financial Services
Alabama
-$175K -11,409 Closed
SG Americas Securities
108
SG Americas Securities
New York
-$104K -6,818 Closed
Canada Life
109
Canada Life
Manitoba, Canada
-$79K -5,150 Closed
AG
110
Aperio Group
California
-$5K -321 Closed
CG
111
Cutler Group
California
-$4K -300 Closed
Federated Hermes
112
Federated Hermes
Pennsylvania
-$3K -196 Closed
MF
113
Manchester Financial
California
-$2K -100 Closed